Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)

March 12, 2025 updated by: Dr. Adi Bin Osman, Hospital Raja Permaisuri Bainun

A Randomized Controlled Trial Comparing Helmet Continuous Positive Airway Pressure (CPAP) vs Facemask CPAP for Treatment of Acute Cardiogenic Pulmonary Edema In The Emergency Department

This study objectively held to compare the physiological outcomes in the non-invasive (NIV) treatment of Acute Cardiogenic Pulmonary Edema (ACPE) patients in the Emergency Department (ED) delivered by helmet CPAP (hCPAP) and facemask CPAP (fCPAP).Patients will be randomized to receive either hCPAP or fCPAP.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Non-invasive ventilation(NIV) has different types of interfaces that had been used in acute cardiogenic pulmonary edema. The appropriate interface is necessary to provide comfort and lead to the success of NIV.

NIV delivered via facemask had been used widely. However, it was associated with leaks and discomfort to the patient.

Helmet continuous positive airway pressure (hCPAP) is an NIV interface that allows the provision of high airway pressures with a minimal leak.

Study Type

Interventional

Enrollment (Actual)

164

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All patients aged more than 18 years old presented with acute cardiogenic pulmonary oedema

Exclusion Criteria:

  1. Age less than 18 years old
  2. Low GCS (less than 8), altered mental status
  3. Hemodynamic instability, impending cardiopulmonary arrest
  4. Use of vasopressors, inotropes
  5. Exacerbation of asthma or chronic respiratory failure
  6. Urgent need for endotracheal intubation
  7. Absence of airway protective gag reflex
  8. Elevated intracranial pressure
  9. Tracheostomy
  10. Pregnant
  11. Upper airway obstruction
  12. Injuries or surgery to head and neck less than 6 months upon presentation
  13. Claustrophobia
  14. Blind or poor vision
  15. Medico-legal related cases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: helmet CPAP
helmet CPAP administer to patient diagnosed as acute cardiogenic pulmonary edema
The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or facemask CPAP.
Active Comparator: facemask CPAP
facemask CPAP administer to patient diagnosed as acute cardiogenic pulmonary edema
The patient presented with Acute Cardiogenic Pulmonary Edema will be randomized into either helmet CPAP or facemask CPAP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Rate
Time Frame: 1 hour
Respiratory rate change post intervention
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: 1 hour
Heart rate change post intervention
1 hour
Partial Pressure of Arterial Oxygen Level
Time Frame: 1 hour
Partial arterial oxygen level post intervention
1 hour
Ratio Of Partial Pressure Arterial Oxygen And Fraction Of Oxygen
Time Frame: 1 hour
Partial arterial oxygen/fraction of oxygen ratio change post intervention
1 hour
Dyspnea Scale
Time Frame: 1 hour
Dyspnea scale improvement post intervention.Dyspnea scale measured using an unmarked 100mm VAS card that had mark with "I can breathe normally", at one end correspond to patients' normal baseline breathing which score "0" and on the other end "I can't breathe at all", which score "100" represent the worst difficulty perceived by patients.
1 hour
Partial Pressure of Arterial Carbon Dioxide level
Time Frame: 1 hour
Partial Pressure of Arterial Carbon Dioxide level change post intervention.
1 hour
Rate of Intubation
Time Frame: 1 hour
Intubation rate post intervention
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adi Osman, Emergency Department, Hospital Raja Permaisuri Bainun

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

January 10, 2018

Study Registration Dates

First Submitted

July 4, 2019

First Submitted That Met QC Criteria

July 4, 2019

First Posted (Actual)

July 10, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NMRR-14-1894-21782 (IIR).

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Cardiogenic Pulmonary Edema

Clinical Trials on hCPAP vs fCPAP

Subscribe